Vibrato Medical, Inc. was founded in 2017 with a mission to be the preferred therapeutic system for patients with reduced tissue perfusion. The company operates in the Health Care industry and is headquartered in the United States. Vibrato Medical has gained attention with its groundbreaking development - the first wearable therapeutic ultrasound device for the noninvasive, outpatient treatment of peripheral arterial disease. This innovative device is designed to promote vasodilation, collateral vessel growth, and angiogenesis, ultimately working to restore perfusion. The company recently secured a significant $4.00M Series A investment on 14 September 2021, with funding coming from the esteemed Horowitz Group. This notable investment is a testament to the potential of Vibrato Medical's technology and its ability to offer a unique solution in the healthcare space.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $1.50M | 1 | National Institutes of Health | 14 Sep 2021 |
| Series A | $4.00M | 1 |
|
14 Sep 2021 |
No recent news or press coverage available for Vibrato Medical, Inc..
We care about your data, and we'd love to use cookies make your experience better.
